GARDskin approved by OECD
THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay
The GARD® technology: An holistic approach
SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.
Press Releases
28 Apr, 2022
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
31 Mar, 2022
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
25 Mar, 2022
News
IR
English
Regulatory
Listing Regulation
Report
Annual
Quick Links
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026






